(Q79359364)

English

The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients

scientific article published on 14 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

object named as

Shiwei Duan

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Qinghe Xing

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Xueqing Qian

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Huafang Li

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Shiming Wong

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Shengnan Wu

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Guoyin Feng

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Mingqing Xu

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Rui Gao

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Wei Qin

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Jianjun Gao

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Junwei Meng

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Lin He

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

14 November 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

The International Journal of Neuropsychopharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

631-637

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone versus haloperidol in psychotic patients with disturbing neuroleptic-induced extrapyramidal symptoms: a double-blind, multi-center trial

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

The 3' region of the DRD2 gene is involved in genetic susceptibility to schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Model-free analysis and permutation tests for allelic associations.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacology and clinical experience with risperidone

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of BPRS-A percent change scores to identify significant clinical improvement: accuracy of treatment response classification in acute psychiatric inpatients

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of dopamine D2 receptor gene polymorphisms as a possible predictor of treatment-resistance to dopamine antagonists in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine receptor polymorphisms and drug response in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacogenetics of dopamine receptors and response to antipsychotic drugs in schizophrenia--an update

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS146114570600719X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S146114570600719X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17105675%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79359364&oldid=1566656747"